Validation of the Persian NDDI-E for Depression Screening in Adolescents with Epilepsy
Iranian Journal of Child Neurology,
Vol. 20 No. 2 (2026),
1 April 2026
,
Page 21-27
https://doi.org/10.22037/ijcn.v20i2.47810
Abstract
Objectives:
Depression is a prevalent comorbidity among individuals with epilepsy, significantly impacting quality of life and healthcare costs. Despite its high occurrence, depression in epilepsy often remains undiagnosed due to clinical time constraints and the lack of efficient screening tools. The Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) has demonstrated high sensitivity and specificity for detecting depression in adults with epilepsy. However, its effectiveness in adolescents remains underexplored. This study aimed to evaluate the validity and reliability of the Persian version of the NDDI-E in screening for depression among adolescents with epilepsy and to identify potential risk factors associated with depression in this population.
Materials & Methods:
A cross-sectional study was conducted on 100 consecutively recruited adolescents (aged 12–18 years; 71 females, 29 males) diagnosed with epilepsy at Zahra Mardani Azari Children’s Hospital. Participants completed the Persian NDDI-E, and results were compared to diagnoses obtained via the gold-standard K-SADS-PL interview administered by trained clinicians. Reliability was assessed using Cronbach’s alpha, and validity was examined through sensitivity, specificity, and predictive values. Statistical analyses were performed using SPSS 26.
Results:
The NDDI-E demonstrated high sensitivity (81.48%) and specificity (95.89%) in detecting depression. Depression prevalence was 25% based on NDDI-E and 27% based on K-SADS-PL. Cronbach’s alpha indicated good internal consistency (α = 0.82). A significant association was found between juvenile myoclonic epilepsy (JME) and depression, while other seizure types showed no correlation.
Conclusion:
The Persian NDDI-E proves to be a valid and reliable screening tool for depression in adolescents with epilepsy, facilitating early detection and intervention in busy clinical settings. Routine screening is recommended to improve patient outcomes, though larger multicenter studies are needed to confirm these findings
- Epilepsy
- Depression
- NDDI-E
- Adolescents
- Screening Tool
How to Cite
References
De Oliveira GN, Lessa JMK, Gonçalves AP, Portela EJ, Sander JW, Teixeira AL. Screening for depression in people with epilepsy: comparative study among neurological disorders depression inventory for epilepsy (NDDI-E), hospital anxiety and depression scale depression subscale (HADS-D), and Beck depression inventory (BDI). Epilepsy & Behavior. 2014;34:50-4.
Di Capua D, Garcia-Garcia ME, Reig-Ferrer A, Fuentes-Ferrer M, Toledano R, Gil-Nagel A, et al. Validation of the Spanish version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy & Behavior. 2012;24(4):493-6.
Gilliam FG, Barry JJ, Hermann BP, Meador KJ, Vahle V, Kanner AM. Rapid detection of major depression in epilepsy: a multicentre study. The Lancet Neurology. 2006;5(5):399-405.
Ko P-W, Hwang J, Lim H-W, Park S-P. Reliability and validity of the Korean version of the Neurological Disorders Depression Inventory for Epilepsy (K-NDDI-E). Epilepsy & Behavior. 2012;25(4):539-42.
Friedman DE, Kung DH, Laowattana S, Kass JS, Hrachovy RA, Levin HS. Identifying depression in epilepsy in a busy clinical setting is enhanced with systematic screening. Seizure. 2009;18(6):429-33.
Vaighan NS, Kasmaei HD, Hesami O, Azargashb E, Alsharieh AM. Evaluation of reliability and validity of the Persian version of the Neurological Disorders Depression Inventory for Epilepsy (P-NDDI-E). Epilepsy & Behavior. 2021;114:107457.
Metternich B, Wagner K, Buschmann F, Anger R, Schulze-Bonhage A. Validation of a German version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy & Behavior. 2012;25(4):485-8.
Micoulaud-Franchi J-A, Barkate G, Trébuchon-Da Fonseca A, Vaugier L, Gavaret M, Bartolomei F, et al. One step closer to a global tool for rapid screening of major depression in epilepsy: validation of the French NDDI-E. Epilepsy & Behavior. 2015;44:11-6.
Rashid H, Katyal J, Tripathi M, Sood M, Gupta YK. Validation of the Indian version of neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy & Behavior. 2019;95:75-8.
Cengiz GF, Tanık N. Validity and reliability of the Turkish version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E). Epilepsy & Behavior. 2019;99:106471.
Shih Y-C, Chou C-C, Lu Y-J, Chou Y-H, Yu H-Y. Reliability and validity of the Taiwanese version of the Neurological Disorders Depression Inventory for Epilepsy (Tw-NDDI-E). Seizure. 2020;81:53-7.
Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J, Dahl RE, et al. Childhood and adolescent depression: a review of the past 10 years. Part I. Journal of the American Academy of Child & Adolescent Psychiatry. 1996;35(11):1427-39.
Lewinsohn PM, Clarke GN, Seeley JR, Rohde P. Major depression in community adolescents: age at onset, episode duration, and time to recurrence. Journal of the American Academy of Child & Adolescent Psychiatry. 1994;33(6):809-18.
Scott AJ, Sharpe L, Loomes M, Gandy M. Systematic review and meta-analysis of anxiety and depression in youth with epilepsy. Journal of pediatric psychology. 2020;45(2):133-44.
Seyfhashemi M, Bahadoran P. Depression in children and adolescents with epilepsy: a 15 year research review of prevalence, and demographic and seizure related correlates. Iranian journal of pediatrics. 2013;23(1):1.
Ettinger AB, Weisbrot DM, Nolan EE, Gadow KD, Vitale SA, Andriola MR, et al. Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia. 1998;39(6):595-9.
Dunn DW, Austin JK, Huster GA. Symptoms of depression in adolescents with epilepsy. Journal of the American Academy of Child & Adolescent Psychiatry. 1999;38(9):1132-8.
Adewuya AO, Ola BA. Prevalence of and risk factors for anxiety and depressive disorders in Nigerian adolescents with epilepsy. Epilepsy & behavior. 2005;6(3):342-7.
Oguz A, Kurul S, Dirik E, Eylül D. Relationship of epilepsy-related factors to anxiety and depression scores in epileptic children. Journal of child neurology. 2002;17(1):37-40.
Ott D, Caplan R, Guthrie D, Siddarth P, Komo S, Shields WD, et al. Measures of psychopathology in children with complex partial seizures and primary generalized epilepsy with absence. Journal of the American Academy of Child & Adolescent Psychiatry. 2001;40(8):907-14.
Caplan R, Siddarth P, Gurbani S, Hanson R, Sankar R, Shields WD. Depression and anxiety disorders in pediatric epilepsy. Epilepsia. 2005;46(5):720-30.
Thome-Souza S, Kuczynski E, Assumpção Jr F, Rzezak P, Fuentes D, Fiore L, et al. Which factors may play a pivotal role on determining the type of psychiatric disorder in children and adolescents with epilepsy? Epilepsy & Behavior. 2004;5(6):988-94.
de Araújo Filho GM, Pascalicchio TF, Lin K, Guilhoto LMF, Yacubian EMT. Psychiatric disorders in juvenile myoclonic epilepsy: a controlled study of 100 patients. Epilepsy & Behavior. 2007;10(3):437-41.
Perini G, Tosin C, Carraro C, Bernasconi G, Canevini M, Canger R, et al. Interictal mood and personality disorders in temporal lobe epilepsy and juvenile myoclonic epilepsy. Journal of Neurology, Neurosurgery & Psychiatry. 1996;61(6):601-5.
- Abstract Viewed: 50 times